Detalhe da pesquisa
1.
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Future Oncol
; 19(10): 727-736, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133230
2.
Tamoxifen related chorioretinal structural changes.
Cutan Ocul Toxicol
; 42(3): 109-117, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272809
3.
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study.
Future Oncol
; 18(23): 2573-2582, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734870
4.
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group).
Turk J Med Sci
; 52(4): 1022-1032, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36326360
5.
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database.
Future Oncol
; 17(35): 4861-4869, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726480
6.
[Clinical features of the ALK-mutant non-small cell lung cancer patients who received first-line alectinib treatment]. / Birinci basamak alektinib tedavisi alan ALK mutasyonu pozitif akciger kanseri hastalarinin klinik özelliklerinin degerlendirilmesi.
Tuberk Toraks
; 69(3): 321-327, 2021 Sep.
Artigo
em Turco
| MEDLINE | ID: mdl-34581153
7.
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer.
J Oncol Pharm Pract
; 26(5): 1110-1116, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31653193
8.
Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study).
J Oncol Pharm Pract
; 26(7): 1583-1589, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32054412
9.
The association of clinicopathologic features and peripheral blood parameters with high PD-L1 expression in non-small cell lung cancer.
Tuberk Toraks
; 68(2): 118-125, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32755111
10.
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma.
N Engl J Med
; 383(7): 694, 2020 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32786199
11.
Adjuvant Capecitabine for Breast Cancer.
N Engl J Med
; 377(8): 791, 2017 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28834475
12.
Do tyrosine kinase inhibitors lose favor in treatment of first-line metastatic renal cell carcinoma?
Future Oncol
; 15(9): 925-927, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30854890
13.
Optimal regimen for treatment-naive hormone receptor-positive HER-2 negative metastatic breast cancer.
Future Oncol
; 15(2): 105-107, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30484708
14.
Mutational status of lung cancer patients and survival outcomes for patients with limited brain metastases.
J BUON
; 23(7): 156, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30722126
15.
Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations.
J Cancer Res Ther
; 19(2): 347-354, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37006071
16.
External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.
Clin Genitourin Cancer
; 21(1): 175-182, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970759
17.
The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study).
J Cancer Res Clin Oncol
; 149(8): 4141-4148, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048274
18.
Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer.
Future Oncol
; 13(22): 1911-1913, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28829190
19.
The current status of adjuvant treatment for high-risk renal cell carcinoma.
Future Oncol
; 13(23): 2017-2020, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28984480
20.
Do all aromatase inhibitors have similar efficacy and safety?
Future Oncol
; 13(19): 1673-1676, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28831832